Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities
Authors:
- David W. DenningDDDavid W. Denning
- David S. PerlinDPDavid S. Perlin
- Eavan G. MuldoonEMEavan G. Muldoon
- Arnaldo Lopes ColomboArnaldo Lopes Colombo
- Arunaloke ChakrabartiACArunaloke Chakrabarti
- Malcolm D. RichardsonMRMalcolm D. Richardson
- Tania C. SorrellTSTania C. Sorrell
Open Access
- 1 February 2017
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 23 (2) , 177-183
Abstract
Antimicrobial resistance, a major public health concern, largely arises from excess use of antibiotic and antifungal drugs. Lack of routine diagnostic testing for fungal diseases exacerbates the problem of antimicrobial drug empiricism, both antibiotic and antifungal. In support of this contention, we cite 4 common clinical situations that illustrate this problem: 1) inaccurate diagnosis of fungal sepsis in hospitals and intensive care units, resulting in inappropriate use of broad-spectrum antibacterial drugs in patients with invasive candidiasis; 2) failure to diagnose chronic pulmonary aspergillosis in patients with smear-negative pulmonary tuberculosis; 3) misdiagnosis of fungal asthma, resulting in unnecessary treatment with antibacterial drugs instead of antifungal drugs and missed diagnoses of life-threatening invasive aspergillosis in patients with chronic obstructive pulmonary disease; and 4) overtreatment and undertreatment of Pneumocystis pneumonia in HIV-positive patients. All communities should have access to nonculture fungal diagnostics, which can substantially benefit clinical outcome, antimicrobial stewardship, and control of antimicrobial resistance.Keywords
This publication has 42 references indexed in Scilit:
- Evaluation of PCR in Bronchoalveolar Lavage Fluid for Diagnosis of Pneumocystis jirovecii Pneumonia: A Bivariate Meta-Analysis and Systematic ReviewPLOS ONE, 2013
- Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-RegressionPLOS ONE, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream InfectionAntimicrobial Agents and Chemotherapy, 2012
- Diagnostic Accuracy of Serum 1,3-β- d -Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-AnalysisJournal of Clinical Microbiology, 2012
- Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosisBulletin of the World Health Organization, 2011
- PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-AnalysisJournal of Clinical Microbiology, 2011
- Trends in COPD mortality and hospitalizations in countries and regions of Asia‐PacificRespirology, 2008
- Active Surveillance of Candidemia, AustraliaEmerging Infectious Diseases, 2006
- Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical CentersJournal of Clinical Microbiology, 2006